
Molina Healthcare Inc: shareholders and insiders
Price
$206.56
November 18, 2026Market cap $10.6B
What Ploutos Investor adds for Molina Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 16, 2026, from their own Form 4 filings.
Bought on the market
$100.1K
1 person
Sold on the market
$5.8M
6 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $100.1K by 1 person·sold $5.8M by 6 people
- 2025: no buys, sold $51.1K by 1 person
- 2026: bought $100.1K by 1 person, sold $5.8M by 6 people
- Nov 16, 2026Steven J OrlandoDirectorKind
- Nov 13, 2026Dale B WolfDirectorKind
- Nov 13, 2026Joseph M ZubretskyPresident & CEOKind
- Nov 10, 2026Richard M SchapiroDirectorKind
- Nov 10, 2026Jeff D. BarlowChief Legal OfficerKind
- Oct 1, 2026Richard C ZoreticDirectorKind
- Oct 1, 2026Dale B WolfDirectorKind
- Oct 1, 2026Richard M SchapiroDirectorKind
- Oct 1, 2026Ronna RomneyDirectorKind
- Oct 1, 2026Steven J OrlandoDirectorKind
- Oct 1, 2026Stephen H LockhartDirectorKind
- Oct 1, 2026Leo P GrohowskiDirectorKind
- Oct 1, 2026Francis S Soistman JrDirectorKind
- Oct 1, 2026Barbara L BrasierDirectorKind
- Jul 1, 2026Richard C ZoreticDirectorKind
- Jul 1, 2026Dale B WolfDirectorKind
- Jul 1, 2026Richard M SchapiroDirectorKind
- Jul 1, 2026Ronna RomneyDirectorKind
- Jul 1, 2026Steven J OrlandoDirectorKind
- Jul 1, 2026Stephen H LockhartDirectorKind
- Jul 1, 2026Leo P GrohowskiDirectorKind
- Jul 1, 2026Francis S Soistman JrDirectorKind
- Jul 1, 2026Barbara L BrasierDirectorKind
- Jul 1, 2026Debra BaconEVP, MedicaidKind
- Jun 30, 2026James WoysChief Operating OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Steven J OrlandoDirector | 702 | $227.33 | $159.6K | Form 4 | |
| Nov 13, 2026 | Dale B WolfDirector | 1,600 | $206.12 | $329.8K | Form 4 | |
| Nov 13, 2026 | Joseph M ZubretskyPresident & CEO | 6,500 | – | – | Form 4 | |
| Nov 10, 2026 | Richard M SchapiroDirector | 782 | $203.94 | $159.5K | Form 4 | |
| Nov 10, 2026 | Jeff D. BarlowChief Legal Officer | 8,000 | $203.07 | $1.6M | Form 4 | |
| Oct 1, 2026 | Richard C ZoreticDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Dale B WolfDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Richard M SchapiroDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Ronna RomneyDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Steven J OrlandoDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Stephen H LockhartDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Leo P GrohowskiDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Francis S Soistman JrDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Oct 1, 2026 | Barbara L BrasierDirector | 304 | $180.85 | $55.0K | Form 4 | |
| Jul 1, 2026 | Richard C ZoreticDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Dale B WolfDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Richard M SchapiroDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Ronna RomneyDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Steven J OrlandoDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Stephen H LockhartDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Leo P GrohowskiDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Francis S Soistman JrDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Barbara L BrasierDirector | 237 | $232.55 | $55.1K | Form 4 | |
| Jul 1, 2026 | Debra BaconEVP, Medicaid | 183 | $232.55 | $42.6K | Form 4 | |
| Jun 30, 2026 | James WoysChief Operating Officer | 144 | $147.51 | $21.2K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by MOH's officers and directors from 2006 up to November 18, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class9.20%
- AQR Capital Management, LLCwith 1 more personShare of class6.83%
- Giovanni Agnelli B.V.with 3 more personsShare of class5.21%
- Vanguard Capital ManagementShare of class5.19%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.20% | 4.81M | Oct 27, 20263 filings since Jan 21, 2026 | 13G/A | |
| AQR Capital Management, LLCwith 1 more person | 6.83% | 3.56M | Aug 13, 20264 filings since Nov 14, 2025 | 13G/A | |
| Giovanni Agnelli B.V.with 3 more persons | 5.21% | 2.72M | Sep 3, 2026 | 13G | |
| Vanguard Capital Management | 5.19% | 2.70M | Apr 30, 2026 | 13G |
Fell to 5% or less (6)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Baupost (Klarman)In the quarter-29%
- AQR CapitalIn the quarter-1.5%
- Point72 (Cohen)In the quarter
- Renaissance TechnologiesIn the quarter+4.1%
- Bridgewater (Dalio)In the quarter+479%
- D.E. ShawIn the quarter+65%
- Citadel Advisors (Griffin)In the quarter+412%
- Millennium Mgmt (Englander)In the quarter-3.6%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Baupost (Klarman) | 449.6K | -29% | $85M | 1.68% |
| AQR Capital | 3.51M | -1.5% | $655M | 0.19% |
| Point72 (Cohen) | 253.6K | $48M | 0.08% | |
| Renaissance Technologies | 328.0K | +4.1% | $62M | 0.08% |
| Bridgewater (Dalio) | 48.2K | +479% | $9.1M | 0.04% |
| D.E. Shaw | 344.2K | +65% | $65M | 0.04% |
| Citadel Advisors (Griffin) | 218.6K | +412% | $41M | 0.02% |
| Millennium Mgmt (Englander) | 79.9K | -3.6% | $15M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 5.81% of its shares outstanding were held short, +3.7% since the report before.
- Shares held short
- 2.99M
- 5.81%
- Since the report before2.89M on Sep 30, 2026
- +3.7%
- 3.7
- 814.3K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 44%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.05M
- Nov 15, 2023: Shares held short 1.94M
- Nov 30, 2023: Shares held short 1.95M
- Dec 15, 2023: Shares held short 1.71M
- Dec 29, 2023: Shares held short 1.71M
- Jan 12, 2024: Shares held short 1.58M
- Jan 31, 2024: Shares held short 1.55M
- Feb 15, 2024: Shares held short 1.66M
- Feb 29, 2024: Shares held short 1.29M
- Mar 15, 2024: Shares held short 1.43M
- Mar 28, 2024: Shares held short 1.15M
- Apr 15, 2024: Shares held short 956.1K
- Apr 30, 2024: Shares held short 1.18M
- May 15, 2024: Shares held short 1.34M
- May 31, 2024: Shares held short 1.62M
- Jun 14, 2024: Shares held short 1.61M
- Jun 28, 2024: Shares held short 1.71M
- Jul 15, 2024: Shares held short 1.90M
- Jul 31, 2024: Shares held short 1.58M
- Aug 15, 2024: Shares held short 1.32M
- Aug 30, 2024: Shares held short 1.37M
- Sep 13, 2024: Shares held short 1.33M
- Sep 30, 2024: Shares held short 1.14M
- Oct 15, 2024: Shares held short 1.17M
- Oct 31, 2024: Shares held short 888.4K
- Nov 15, 2024: Shares held short 997.4K
- Nov 29, 2024: Shares held short 963.9K
- Dec 13, 2024: Shares held short 1.04M
- Dec 31, 2024: Shares held short 1.10M
- Jan 15, 2025: Shares held short 1.14M
- Jan 31, 2025: Shares held short 1.04M
- Feb 14, 2025: Shares held short 1.40M
- Feb 28, 2025: Shares held short 1.72M
- Mar 14, 2025: Shares held short 1.75M
- Mar 31, 2025: Shares held short 1.28M
- Apr 15, 2025: Shares held short 1.30M
- Apr 30, 2025: Shares held short 954.8K
- May 15, 2025: Shares held short 1.09M
- May 30, 2025: Shares held short 1.07M
- Jun 13, 2025: Shares held short 1.24M
- Jun 30, 2025: Shares held short 1.17M
- Jul 15, 2025: Shares held short 1.08M
- Jul 31, 2025: Shares held short 1.75M
- Aug 15, 2025: Shares held short 2.24M
- Aug 29, 2025: Shares held short 2.92M
- Sep 15, 2025: Shares held short 3.06M
- Sep 30, 2025: Shares held short 3.38M
- Oct 15, 2025: Shares held short 3.22M
- Oct 31, 2025: Shares held short 3.14M
- Nov 14, 2025: Shares held short 3.86M
- Nov 28, 2025: Shares held short 4.39M
- Dec 15, 2025: Shares held short 3.62M
- Dec 31, 2025: Shares held short 3.61M
- Jan 15, 2026: Shares held short 3.04M
- Jan 30, 2026: Shares held short 2.89M
- Feb 13, 2026: Shares held short 3.77M
- Feb 27, 2026: Shares held short 3.55M
- Mar 13, 2026: Shares held short 3.24M
- Mar 31, 2026: Shares held short 3.46M
- Apr 15, 2026: Shares held short 3.08M
- Apr 30, 2026: Shares held short 3.56M
- May 15, 2026: Shares held short 2.91M
- May 29, 2026: Shares held short 2.53M
- Jun 15, 2026: Shares held short 3.00M
- Jun 30, 2026: Shares held short 3.29M
- Jul 15, 2026: Shares held short 3.33M
- Jul 31, 2026: Shares held short 2.94M
- Aug 14, 2026: Shares held short 2.78M
- Aug 31, 2026: Shares held short 3.08M
- Sep 15, 2026: Shares held short 3.21M
- Sep 30, 2026: Shares held short 2.89M
- Oct 15, 2026: Shares held short 2.99M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading61.4% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 61.4% of the shares in the reported trades were short sales, against 53.1% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 61.4%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 53.1%
- Change
- +8.3 pts
- Short sales a dayon average, of 394.8K shares
- 242.4K
- More than atof 3,656 US-listed companies, same days
- 86%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 62.5%
- Oct 13, 2026: Short sales 58.9%
- Oct 14, 2026: Short sales 43.4%
- Oct 15, 2026: Short sales 29.3%
- Oct 16, 2026: Short sales 30.4%
- Oct 19, 2026: Short sales 43.4%
- Oct 20, 2026: Short sales 48.3%
- Oct 21, 2026: Short sales 56.5%
- Oct 22, 2026: Short sales 68.8%
- Oct 23, 2026: Short sales 55.3%
- Oct 26, 2026: Short sales 58.3%
- Oct 27, 2026: Short sales 64.6%
- Oct 28, 2026: Short sales 47.7%
- Oct 29, 2026: Short sales 57.3%
- Oct 30, 2026: Short sales 59.6%
- Nov 2, 2026: Short sales 69%
- Nov 3, 2026: Short sales 42.8%
- Nov 4, 2026: Short sales 60.6%
- Nov 5, 2026: Short sales 51.1%
- Nov 6, 2026: Short sales 68.2%
- Nov 9, 2026: Short sales 61.3%
- Nov 10, 2026: Short sales 64.4%
- Nov 11, 2026: Short sales 68.8%
- Nov 12, 2026: Short sales 61.1%
- Nov 13, 2026: Short sales 51.6%
- Nov 16, 2026: Short sales 63.3%
- Nov 17, 2026: Short sales 65.1%
- Nov 18, 2026: Short sales 69.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Joseph M ZubretskyPresident & CEODirectly109.3K
- James WoysChief Operating OfficerDirectly90.2K
- Jeff D. BarlowChief Legal OfficerDirectly59.3K
- Mark Lowell KeimChief Financial OfficerDirectly36.5K
- Debra BaconEVP, MedicaidDirectly21.6K
- Steven J OrlandoDirectorDirectly2,526
- Ronna RomneyDirectorDirectly946
- Dale B WolfDirectorDirectly28
- Maurice HebertChief Accounting OfficerDirectly12.8K
- Richard M SchapiroDirectorDirectly11.8K
- Richard C ZoreticDirectorDirectly946
- Barbara L BrasierDirectorDirectly6,122
- Stephen H LockhartDirectorDirectly4,688
- Leo P GrohowskiDirectorDirectly1,846
- Francis S Soistman JrDirectorDirectly1,211
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Joseph M ZubretskyPresident & CEO | 109.3K | 257.7K | Nov 13, 2026 | Form 4 |
| James WoysChief Operating Officer | 90.2K | – | Jun 30, 2026 | Form 4 |
| Jeff D. BarlowChief Legal Officer | 59.3K | – | Nov 10, 2026 | Form 4 |
| Mark Lowell KeimChief Financial Officer | 36.5K | – | Feb 12, 2024 | Form 4 |
| Debra BaconEVP, Medicaid | 21.6K | – | Jul 1, 2026 | Form 4 |
| Steven J OrlandoDirector | 2,526 | 16.5K | Nov 16, 2026 | Form 4 |
| Ronna RomneyDirector | 946 | 17.2K | Oct 1, 2026 | Form 4 |
| Dale B WolfDirector | 28 | 14.3K | Nov 13, 2026 | Form 4 |
| Maurice HebertChief Accounting Officer | 12.8K | – | May 14, 2026 | Form 4 |
| Richard M SchapiroDirector | 11.8K | – | Nov 10, 2026 | Form 4 |
| Richard C ZoreticDirector | 946 | 8,747 | Oct 1, 2026 | Form 4 |
| Barbara L BrasierDirector | 6,122 | – | Oct 1, 2026 | Form 4 |
| Stephen H LockhartDirector | 4,688 | – | Oct 1, 2026 | Form 4 |
| Leo P GrohowskiDirector | 1,846 | – | Oct 1, 2026 | Form 4 |
| Francis S Soistman JrDirector | 1,211 | – | Oct 1, 2026 | Form 4 |
A lower bound: it counts only the 15 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund1.78%
- IJSiShares S&P Small-Cap 600 Value ETFWeight in the fund1.28%
- SPSMState Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETFWeight in the fund0.65%
- IJRiShares Core S&P Small-Cap ETFWeight in the fund0.64%
- VBRVanguard Small-Cap Value Index FundWeight in the fund0.26%
- SCHMSchwab U.S. Mid-Cap ETFWeight in the fund0.19%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.17%
- DFSVDimensional US Small Cap Value ETFWeight in the fund0.16%
- VBVanguard Small-Cap Index FundWeight in the fund0.14%
- VHTVanguard Health Care Index FundWeight in the fund0.14%
32 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 628
- Q4 2025: Managers 553
- Q1 2026: Managers 530
- Q2 2026: Managers 601
Institutional investors by quarter
The fund managers holding MOH, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 601 managers held 56.26M shares, worth $12.8B. During the quarter 154 opened a position, 83 closed one, 208 added and 171 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+3.2%
- AQR CapitalIn the quarter+24%
- Vanguard Portfolio ManagementIn the quarter
- Capital World InvestorsIn the quarter-20%
- Lingotto Investment ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter+1.9%
- Victory Capital ManagementIn the quarter-4.4%
- FMRIn the quarter-42%
- State StreetIn the quarter+1.4%
- Dimensional Fund AdvisorsIn the quarter-0.1%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 6.57M | +3.2% | $1.5B |
| AQR Capital | 3.56M | +24% | $807M |
| Vanguard Portfolio Management | 2.79M | $638M | |
| Capital World Investors | 2.56M | -20% | $586M |
| Lingotto Investment Management | 2.51M | $574M | |
| Vanguard Capital Management | 2.36M | +1.9% | $539M |
| Victory Capital Management | 1.98M | -4.4% | $453M |
| FMR | 1.87M | -42% | $428M |
| State Street | 1.76M | +1.4% | $401M |
| Dimensional Fund Advisors | 1.39M | -0.1% | $319M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Molina Healthcare's filings show?
Who buys and sells is one part of Molina Healthcare's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have MOH's insiders bought or sold?
From Jul 2, 2026 to Nov 16, 2026 Molina Healthcare's insiders bought 0 and sold $2.3M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold MOH?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $655M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.